Sign In

Login

Password

Forgot Password ? Sign Up

Bupropion (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Bupropion" in German language version.

refsWebsite
Global rank German rank
19nih.gov
4th place
7th place
14doi.org
2nd place
3rd place
5web.archive.org
1st place
1st place
3books.google.com
3rd place
67th place
2apotheken-umschau.de
low place
1,907th place
1sigmaaldrich.com
924th place
87th place
1who.int
195th place
255th place
1zdf.de
1,243rd place
75th place
1iqwig.de
low place
3,381st place
1wiley.com
222nd place
272nd place
1karger.com
4,489th place
3,288th place
1deutsche-apotheker-zeitung.de
low place
797th place
1espacenet.com
800th place
160th place
1nami.org
low place
low place
1rxlist.com
7,927th place
low place
1diepresse.com
1,466th place
97th place
1bfarm.de
low place
1,217th place

apotheken-umschau.de

bfarm.de

books.google.com

deutsche-apotheker-zeitung.de

diepresse.com

doi.org

  • Hugo R. Arias, Abel Santamaría, Syed Ali: Pharmacological and Neurotoxicological Actions Mediated By Bupropion and Diethylpropion. Academic Press, 1. Januar 2009, Chapter 9, S. 223–255, doi:10.1016/s0074-7742(09)88009-4.
  • P. S. Masand, A. K. Ashton, S. Gupta, B. Frank: Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study. In: The American Journal of Psychiatry. Band 158, Nummer 5, Mai 2001, S. 805–807, doi:10.1176/appi.ajp.158.5.805, PMID 11329407.
  • K. Cahill, L. F. Stead, T. Lancaster: Nicotine receptor partial agonists for smoking cessation. In: Cochrane Database of Systematic Reviews. Nr. 1, 2007, Art. No.: CD006103. doi:10.1002/14651858.CD006103.pub2.
  • A. M. Lee, C. Jepson, E. Hoffmann, L. Epstein, L. W. Hawk, C. Lerman, R. F. Tyndale: CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial. In: Biological psychiatry. Band 62, Nr. 6, September 2007, S. 635–641, doi:10.1016/j.biopsych.2006.10.005. PMID 17223085.
  • Friedrich Linderkamp, Gerhard Lauth: Zur Wirksamkeit pharmakologischer und psychotherapeutischer Therapien bei Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) im Erwachsenenalter. In: Verhaltenstherapie. Band 21, Nr. 4, 2011, S. 229–238, doi:10.1159/000332429 (karger.com [PDF]).
  • J. W. Anderson, F. L. Greenway, K. Fujioka, K. M. Gadde, J. McKenney, P. M. O'Neil: Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial. In: Obesity research. Band 10, Nr. 7, Juli 2002, S. 633–641, doi:10.1038/oby.2002.86. PMID 12105285.
  • Kishore M Gadde, Glen L Xiong: Bupropion for weight reduction. In: Expert Review of Neurotherapeutics. 7, 2007, S. 17, doi:10.1586/14737175.7.1.17.
  • Susan M Learned-Coughlin et al.: In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography. In: Elsevier (Hrsg.): Biological Psychiatry. Band 54, Nr. 8, 15. Oktober 2003, S. 800–805, doi:10.1016/s0006-3223(02)01834-6.
  • Jeffrey H. Meyer et al.: Bupropion occupancy of the dopamine transporter is low during clinical treatment. In: Psychopharmacology. Band 163, Nr. 1, 13. Juli 2002, S. 102–105, doi:10.1007/s00213-002-1166-3.
  • W. D. Horst, S. H. Preskorn: Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion. In: J. Affect. Disord. 51, 1998, S. 237–254, doi:10.1016/S0165-0327(98)00222-5.
  • P. M. O’Byrne, R. Williams, J. J. Walsh, J. F. Gilmer: The aqueous stability of bupropion. In: J. Pharm. Biomed. Anal. 53, 2010, S. 376–381. doi:10.1016/j.jpba.2010.04.024.
  • E. Maccaroni, L. Malpezzi, A. Famulari, N. Masciocchi: Structural and energetic aspects of a new bupropion hydrochloride polymorph. In: J. Pharm. Biomed. Anal. 60, 2012, S. 65–70. doi:10.1016/j.jpba.2011.10.031.
  • D. M. Perrine, J. T. Ross, S. J. Nervi, R. H. Zimmerman: A Short, One-Pot Synthesis of Bupropion. In: J. Chem. Ed. 77, 2000, S. 1479. doi:10.1021/ed077p1479.
  • Gerald Zernig, Harriet De Wit u. a.: Subjective Effects of Slow-Release Bupropion versus Caffeine as Determined in a Quasi-Naturalistic Setting. In: Pharmacology. 70, 2004, S. 206, doi:10.1159/000075550.

espacenet.com

worldwide.espacenet.com

  • Patent US3819706A: Meta chloro substituted-α-butylamino-propiophenones. Angemeldet am 30. November 1970, veröffentlicht am 25. Juni 1974, Anmelder: Burroughs Wellcome Co, Erfinder: Nariman B. Metha.‌

iqwig.de

karger.com

  • Friedrich Linderkamp, Gerhard Lauth: Zur Wirksamkeit pharmakologischer und psychotherapeutischer Therapien bei Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) im Erwachsenenalter. In: Verhaltenstherapie. Band 21, Nr. 4, 2011, S. 229–238, doi:10.1159/000332429 (karger.com [PDF]).

nami.org

nih.gov

ncbi.nlm.nih.gov

  • Papakostas u. a.: Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies. In: J Clin Psychiatry. 69(8), Aug 2008, S. 1287–1292. PMID 18605812.
  • M. Fava, A. J. Rush, M. E. Thase, A. Clayton, S. M. Stahl, J. F. Pradko, J. A. Johnston: 15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL. In: Prim Care Companion J Clin Psychiatry. Band 7, Nr. 3, 2005, S. 106–113, PMID 16027765, PMC 1163271 (freier Volltext).
  • E. H. Turner, A. M. Matthews u. a.: Selective publication of antidepressant trials and its influence on apparent efficacy. In: N Engl J Med. 358(3), 17 Jan 2008, S. 252–260. PMID 18199864.
  • P. S. Masand, A. K. Ashton, S. Gupta, B. Frank: Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study. In: Am J Psychiatry. 158(5), May 2001, S. 805–807. PMID 11329407.
  • A. H. Clayton, J. K. Warnock, S. G. Kornstein, R. Pinkerton, A. Sheldon-Keller, E. L. McGarvey: A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. In: J Clin Psychiatry. 65(1), Jan 2004, S. 62–67. PMID 14744170.
  • P. S. Masand, A. K. Ashton, S. Gupta, B. Frank: Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study. In: The American Journal of Psychiatry. Band 158, Nummer 5, Mai 2001, S. 805–807, doi:10.1176/appi.ajp.158.5.805, PMID 11329407.
  • A. H. Clayton, J. K. Warnock, S. G. Kornstein, R. Pinkerton, A. Sheldon-Keller, E. L. McGarvey: A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. In: The Journal of Clinical Psychiatry. Band 65, Nummer 1, Januar 2004, S. 62–67, PMID 14744170.
  • A. M. Lee, C. Jepson, E. Hoffmann, L. Epstein, L. W. Hawk, C. Lerman, R. F. Tyndale: CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial. In: Biological psychiatry. Band 62, Nr. 6, September 2007, S. 635–641, doi:10.1016/j.biopsych.2006.10.005. PMID 17223085.
  • J. W. Anderson, F. L. Greenway, K. Fujioka, K. M. Gadde, J. McKenney, P. M. O'Neil: Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial. In: Obesity research. Band 10, Nr. 7, Juli 2002, S. 633–641, doi:10.1038/oby.2002.86. PMID 12105285.
  • M. E. Thase, A. H. Clayton, B. R. Haight, A. H. Thompson, J. G. Modell, J. A. Johnston: A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability. In: J Clin Psychopharmacol. 26(5), Oct 2006, S. 482–488. PMID 16974189.
  • S. H. Kennedy, K. A. Fulton, R. M. Bagby, A. L. Greene, N. L. Cohen, S. Rafi-Tari: Sexual function during bupropion or paroxetine treatment of major depressive disorder. In: Can J Psychiatry. 51(4), Mar 2006, S. 234–242. PMID 16629348.
  • H. Croft, E. Settle Jr, T. Houser, S. R. Batey, R. M. Donahue, J. A. Ascher: A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. In: Clin Ther. 21(4), Apr 1999, S. 643–658. PMID 10363731.
  • C. C. Coleman, L. A. Cunningham, V. J. Foster, S. R. Batey, R. M. Donahue, T. L. Houser, J. A. Ascher: Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment. In: Ann Clin Psychiatry. 11(4), Dec 1999, S. 205–215. PMID 10596735.
  • R. T. Segraves, R. Kavoussi, A. R. Hughes, S. R. Batey, J. A. Johnston, R. Donahue, J. A. Ascher: Evaluation of sexual functioning in depressed outpatients: a double-blind comparison of sustained-release bupropion and sertraline treatment. In: J Clin Psychopharmacol. 20(2), Apr 2000, S. 122–128. PMID 10770448.
  • A. H. Clayton, H. A. Croft, J. P. Horrigan, D. S. Wightman, A. Krishen, N. E. Richard, J. G. Modell: Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. In: J Clin Psychiatry. 67(5), May 2006, S. 736–746. PMID 16841623.
  • C. C. Coleman, B. R. King, C. Bolden-Watson, M. J. Book, R. T. Segraves, N. Richard, J. Ascher, S. Batey, B. Jamerson, A. Metz: A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine. In: Clin Ther. 23(7), Jul 2001, S. 1040–1058. PMID 11519769.

chem.nlm.nih.gov

pubchem.ncbi.nlm.nih.gov

nimh.nih.gov

rxlist.com

sigmaaldrich.com

web.archive.org

who.int

wiley.com

mrw.interscience.wiley.com

zdf.de